Byline: Genetic Alliance
WASHINGTON, May 20 (AScribe Newswire) -- Earlier today, the National Institutes of Health (NIH) announced the establishment of a new initiative called the Therapeutics for Rare and Neglected Diseases (TRND) Program, a federally mandated effort to encourage and speed the development of new drugs for rare and neglected diseases. Sharon Terry, president and chief executive officer of Genetic Alliance, a nonprofit health advocacy organization, issued the following comments in response to the establishment of TRND:
"Today marks a leap forward in transforming the rare and neglected disease drug development pipeline. NIH is a crucial entity working …
No comments:
Post a Comment